Results 31 to 40 of about 31,338 (290)
The Geographical Distribution of Global Biobanks [PDF]
Cell JournalThis study aimed to comprehensively review the global biobanks to visualize their geographical distribution. The protocolfor this review consisted of the following steps: i.
Farzad Parvizpour +9 more
doaj +1 more source
The UK National Health Service’s 'innovation agenda': lessons on commercialization and trust [PDF]
, 2014 The UK National Health Service (the 'NHS'), encouraged by the 2011 report Innovation Health and Wealth, Accelerating Adoption and Diffusion in the NHS, and empowered by the Health and Social Care Act 2012, is in the process of adopting a new agenda for ...
Cockbain, Julian, Sterckx, Sigrid
core +2 more sources
Introduction : biofutures/biopresents [PDF]
, 2006 Two very different reports produced for the UK government in the last three years have connected the state of our physical health with that of our material wealth. The first of these was produced in 2003 by the Bioscience Innovation and Growth Team (BIGT)
Birch, Kean
core +1 more source
BMC Medical Ethics, 2023 Background Over the last few decades biobanks have been recognised as institutions that may revolutionise biomedical research and the development of personalised medicine.
Jan Domaradzki +2 more
doaj +1 more source
Consent for the use of human biological samples for biomedical research: a mixed methods study exploring the UK public’s preferences [PDF]
, 2013 OBJECTIVE: A mixed-methods study exploring the UK general public's views towards consent for the use of biosamples for biomedical research.<p></p> SETTING: Cross-sectional population-based focus groups followed by an online survey.<p>&
Clotworthy, M +6 more
core +1 more source
Marine Biotechnology: A New Vision and Strategy for Europe [PDF]
, 2013 Marine Board-ESF The Marine Board provides a pan-European platform for its member organisations to develop common priorities, to advance marine research, and to bridge the gap between science and policy in order to meet future marine science challenges ...
Boyen, C. +10 more
core +6 more sources
Clinical trials and the importance of biobanks in rare diseases [PDF]
Scripta Medica, 2018 Rare diseases ('orphan diseases') (RDs) count for 5000-8000 diseases with low prevalence and most commonly of genetic origin. Although most of rare diseases are manifested in early childhood, many are diagnosed in adults, even in elderly.
Nežić Lana +3 more
doaj
The Public’s Awareness of and Attitude Toward Research Biobanks – A Regional German Survey
Frontiers in Genetics, 2018 Background: Biobanks have become an increasingly important means of biomedical research and innovation. However, they entail a variety of ethical, social and legal challenges, which need to be publicly discussed and managed collectively.
Sabine Bossert +2 more
doaj +1 more source
Biobank Economics and the “Commercialization Problem” [PDF]
, 2013 The economic aspects of biobanking are intertwined with the social and scientific aspects. We describe two problems that structure the discussion about the economics of biobanking and which illustrate this intertwining.
Dallaire-Fortier, Clara +2 more
core +3 more sources
FEBS Letters, EarlyView.Bone metastasis in prostate cancer (PCa) patients is a clinical hurdle due to the poor understanding of the supportive bone microenvironment. Here, we identify stearoyl‐CoA desaturase (SCD) as a tumor‐promoting enzyme and potential therapeutic target in bone metastatic PCa.
Alexis Wilson +7 more
wiley +1 more source